HAE logo

HAE Haemonetics Corporation

New York Stock Exchange · Medical - Devices · Healthcare

$122.86
+1.94 (+1.60%)

Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offe…

Market Cap: $5.59Bwww.haemonetics.com

Price

$87.84+46.18%
$52.24$64.11$75.97$87.84
Apr 30Aug 7

Social Signal Score

61
5d
80
1 mentions
+0.0%
30d
58
11 mentions
+0.0%
60d
54
25 mentions
+0.0%
90d
50
32 mentions
+0.0%
news: 25 · rss: 7

Analyst Ratings

21 analysts
Buyconsensus
Strong Buy 0Buy 12Hold 9Sell 0Strong Sell 0
Avg price target$140.71+14.5%
Low $119Median $142High $165
Current Consensus

Revenue

$357.76M+57.02%
$195.58M$249.64M$303.70M$357.76M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$4.54
$4.52–$4.55
7 analysts
FY2026
$4.94+9% YoY
$4.92–$4.97
9 analysts
FY2027
$5.34+8% YoY
$5.28–$5.39
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Christopher A. Simon
Sector
Healthcare
Industry
Medical - Devices
Employees
3,009
Beta
0.54
Country
US
Piotroski score
8 / 9 (Strong)
Altman Z-score
3.51
www.haemonetics.com